New Intranasal Vaccine Shows Promise Against Tuberculosis

New Intranasal Vaccine Shows Promise Against Tuberculosis

Tuberculosis (TB) remains a major global health challenge, causing millions of deaths annually.

concepttuberculosis
concepttb

While the current BCG vaccine helps protect children, it is less effective for adults and fails to provide strong immunity in the lungs.

techbcg vaccine

Recently, researchers from Johns Hopkins Medicine have made an exciting breakthrough by developing a new <span class="annotated" data-start="238" data-end="264" data-value="therapeutic DNA vaccine">therapeutic DNA vaccine</span> for TB.

orgjohns hopkins medicine
techtherapeutic dna vaccine
techtherapeutic dna vaccine
concepttb

Unlike traditional vaccines that aim only to prevent infection, this novel treatment is designed to target drug-tolerant "persister" bacteria, which are the main culprits behind disease relapse.

conceptpersister

What makes this approach particularly innovative is its delivery method: it is administered <span class="annotated" data-start="455" data-end="465" data-value="intranasally">intranasally</span>.

otherintranasally
otherintranasally

By delivering the vaccine directly into the nasal passages, scientists hope to stimulate a robust immune response specifically in the lungs, the primary site of TB infection.

concepttb
๐ŸŽ‰

End of article

You read 6 focus sentences.

Challenge Mode

Comprehension Questions

What is the primary innovation of the new TB vaccine?

โœ“

Correct Choice

It acts as a therapeutic vaccine targeting drug-tolerant persister bacteria.

Why is intranasal delivery considered advantageous for a TB vaccine?

โœ“

Correct Choice

It targets the lungs directly to create a strong local immune response.

What is a major limitation of the currently used BCG vaccine?

โœ“

Correct Choice

It provides limited and waning protection against pulmonary TB in adults.

What are 'persister' bacteria in the context of TB?

โœ“

Correct Choice

Bacteria that survive standard antibiotic treatments and cause relapse.

What is a secondary benefit of intranasal vaccine administration?

โœ“

Correct Choice

It is needle-free and potentially easier to scale for mass campaigns.

Ringoo Icon

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.

New Intranasal Vaccine Shows Promise Against Tuberculosis | Ringoo